Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Glyburide

Maiah D. Hardin, Tibb F. Jacobs  1
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Glyburide

Maiah D. Hardin et al.
Free Books & Documents

Excerpt

According to the 2023 update of the American Diabetes Association Standards of Medical Care in Diabetes, glyburide and other sulfonylureas are considered viable options for adjunctive therapy, particularly for patients seeking potent agents with a higher chance of attaining glycemic targets. This comprehensive overview of glyburide focuses on its indications, mechanism of action, contraindications, adverse event profile, and monitoring considerations. This activity emphasizes the importance of glyburide as an effective therapeutic option in managing type 2 diabetes for interprofessional team members involved in patient care.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Maiah Hardin declares no relevant financial relationships with ineligible companies.

Disclosure: Tibb Jacobs declares no relevant financial relationships with ineligible companies.

References

    1. Glibenclamide: a review. Drugs. 1971;1(2):116-40. - PubMed
    1. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023. Diabetes Care. 2023 Jan 01;46(Suppl 1):S140-S157. - PMC - PubMed
    1. Bouazza N, Djerada Z, Gozalo C, Busiah K, Beltrand J, Berdugo M, Urien S, Treluyer JM, Polak M. Evaluation of the pharmacokinetics of glibenclamide tablet given, off label, orally to children suffering from neonatal syndromic hyperglycemia. Eur J Clin Pharmacol. 2016 Nov;72(11):1373-1379. - PubMed
    1. Beltrand J, Baptiste A, Busiah K, Bouazza N, Godot C, Boucheron A, Djerada Z, Gozalo C, Berdugo M, Tréluyer JM, Elie C, Polak M, GLID-KIR study group Glibenclamide oral suspension: Suitable and effective in patients with neonatal diabetes. Pediatr Diabetes. 2019 May;20(3):246-254. - PubMed
    1. Tsarenko SV, Dzyadz'ko AM, Rybalko SS. [Glibenclamide as a promising agent for prevention and treatment of cerebral edema]. Zh Vopr Neirokhir Im N N Burdenko. 2017;81(3):88-93. - PubMed

Publication types

LinkOut - more resources